ACAD

Acadia Pharmaceuticals Inc

Jun 23 • 04:00PM ET

22.60

+0.51 2.31 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AXSM XENE NBIX BMRN VKTX INCY MDGL ALKS KROS BIIB

| Held by: IJR VTI XBI IWM VB VBK VXF SPSM IBB IJT

Scroll to Statements

Index	RUT	P/E	10.29	EPS (ttm)	2.20	Insider Own	1.31%	Shs Outstand	171.09M	Perf Week	6.28%
Market Cap	3.87B	Forward P/E	29.40	EPS next Y	0.77	Insider Trans	-2.15%	Shs Float	169.00M	Perf Month	6.00%
Enterprise Value	3.07B	PEG	-	EPS next Q	0.06	Inst Own	96.71%	Short Float	6.96%	Perf Quarter	7.67%
Income	375.65M	P/S	3.53	EPS this Y	-83.08%	Inst Trans	-0.61%	Short Ratio	7.22	Perf Half Y	-15.04%
Sales	1.10B	P/B	3.10	EPS next Y	97.54%	ROA	27.44%	Short Interest	11.75M	Perf YTD	-15.39%
Book/sh	7.29	P/C	4.55	EPS next 5Y	-14.50%	ROE	37.32%	52W High	28.35 -20.28%	Perf Year	0.53%
Cash/sh	4.97	P/FCF	34.07	EPS past 3/5Y	- -	ROIC	29.19%	52W Low	19.69 14.78%	Perf 3Y	-7.79%
Dividend Est.	-	EV/EBITDA	33.11	Sales past 3/5Y	27.48% 19.39%	Gross Margin	91.47%	Volatility	3.43% 2.87%	Perf 5Y	-7.83%
Dividend TTM	-	EV/Sales	2.80	EPS Y/Y TTM	61.40%	Oper. Margin	7.39%	ATR (14)	0.67	Perf 10Y	-32.54%
Dividend Ex-Date	-	Quick Ratio	3.48	Sales Y/Y TTM	9.93%	Profit Margin	34.30%	RSI (14)	61.26	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	3.59	EPS Q/Q	-81.36%	SMA20	5.06%	Beta	0.82	Target Price	31.65
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	9.72%	SMA50	4.11%	Rel Volume	0.91	Prev Close	22.09
Employees	798	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-2.83%	Avg Volume	1.63M	Price	22.60
IPO	May 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-60.40% -4.34%	Trades		Volume	1,476,896	Change	2.31%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)